Erratum to: Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer

被引：0
|
作者：
Carlos Caicedo
Maria Jose Garcia-Velloso
Maria Dolores Lozano
Tania Labiano
Carmen Vigil-Diaz
Jose Maria Lopez-Picazo
Alfonso Gurpide
Javier J. Zulueta
Jose Angel Richter-Echevarria
Jose Luis Perez-Gracia
机构：
[1] University of Navarra,Nuclear Medicine Department, University Clinic of Navarra
[2] University of Navarra,Pathology Department, University Clinic of Navarra
[3] University of Navarra,Oncology Department, University Clinic of Navarra
[4] University of Navarra,Pulmonology Department, University Clinic of Navarra
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2164 / 2164
相关论文
共 50 条
  • [41] EGFR Mutation Prediction Using F18-FDG PET-CT Based Radiomics Features in Non-small Cell Lung Cancer
    Henriquez, H.
    Fuentes, D.
    Suarez, F.
    Gonzalez, P.
    INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS 2022, ICBHI 2022, 2024, 108 : 24 - 34
  • [42] EGFR and KRAS Mutational Status and Significance in Greek Patients with Advanced Non Small Cell Lung Cancer
    Linardou, H.
    Kotoula, V.
    Kouvatseas, G.
    Karavasilis, V.
    Mountzios, G.
    Samantas, E.
    Kalogera-Fountzila, A.
    Televantou, D.
    Papadopoulou, K.
    Mavropoulou, X.
    Daskalaki, E.
    Zaramboukas, T.
    Efstratiou, I.
    Lambaki, S.
    Rallis, G.
    Res, E.
    Syrigos, K.
    Kosmidis, P.
    Pectasides, D.
    Fountzilas, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S890 - S890
  • [43] Identification of EGFR mutation status in male patients with non-small-cell lung cancer: role of 18F-FDG PET/CT and serum tumor markers CYFRA21-1 and SCC-Ag
    Maoqing Jiang
    Ping Chen
    Xiuyu Guo
    Xiaohui Zhang
    Qiaoling Gao
    Jingfeng Zhang
    Guofang Zhao
    Jianjun Zheng
    EJNMMI Research, 13
  • [44] Identification of EGFR mutation status in male patients with non-small-cell lung cancer: role of 18F-FDG PET/CT and serum tumor markers CYFRA21-1 and SCC-Ag
    Jiang, Maoqing
    Chen, Ping
    Guo, Xiuyu
    Zhang, Xiaohui
    Gao, Qiaoling
    Zhang, Jingfeng
    Zhao, Guofang
    Zheng, Jianjun
    EJNMMI RESEARCH, 2023, 13 (01)
  • [45] Prognostic role of [18F]FDG PET-CT after induction chemotherapy for locally advanced Non Small Lung Cancer
    Masarykova, A.
    Scepanovic, D.
    Povinec, P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S956 - S957
  • [46] FDG Uptake in Non-Small Cell Lung Cancer Is Not an Independent Predictor of EGFR or KRAS Mutation Status A Retrospective Analysis of 206 Patients
    Lee, Seok Mo
    Bae, Sang Kyun
    Jung, Soo Jin
    Kim, Chun K.
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (12) : 950 - 958
  • [47] Prognostic value of 18F-FDG PET parameters in patients with locally advanced non-small-cell lung cancer treated with induction chemotherapy
    Lee, H. Y.
    Choi, W. H.
    Kim, J-O.
    Yoo, I. R.
    Park, J. K.
    Sung, S. W.
    Kim, Y. S.
    Kang, J. H.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Impact of 18F FDG PET/CT on staging of non-small cell lung cancer.
    Promteangtrong, Chetsadaporn
    Kunawudhi, Anchisa
    Phadungrerk, Rossarin
    Lamsa-art, Chanidapa
    Chotipanich, Chanisa
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma
    Takamochi, Kazuya
    Mogushi, Kaoru
    Kawaji, Hideya
    Imashimizu, Kota
    Fukui, Mariko
    Oh, Shiaki
    Itoh, Masayoshi
    Hayashizaki, Yoshihide
    Ko, Weijey
    Akeboshi, Masao
    Suzuki, Kenji
    PLOS ONE, 2017, 12 (04):
  • [50] Molecular irradiation planning using F-18FDG-PET in non-small-cell lung cancer
    Schmuecking, M
    Baum, RP
    Liesenfeld, S
    Leonhardi, J
    Scheithauer, M
    Presselt, N
    Niesen, A
    Bonnet, R
    Schalldach, U
    Wendt, T
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 57 - 57
12345